MELD score predicts 1-year patient survival post-orthotopic liver transplantation

被引:171
作者
Saab, S
Wang, V
Ibrahim, AB
Durazo, F
Han, S
Farmer, DG
Yersiz, H
Morrisey, M
Goldstein, LI
Ghobrial, RM
Busuttil, RW
机构
[1] Univ Calif Los Angeles, Ctr Med, Div Digest Dis, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Dumont Liver Transplant Ctr, Los Angeles, CA 90095 USA
[3] W Los Angeles Vet Adm Med Ctr, Dept Med, Los Angeles, CA USA
[4] Univ Calif Los Angeles, Dept Biostat, Los Angeles, CA 90024 USA
关键词
D O I
10.1053/jlts.2003.50090
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The Model for End-Stage Liver Disease (MELD) is an important predictor in patients awaiting orthotopic liver transplantation (OLT). However, the model's association with posttransplant patient survival is unclear. We studied 1-year patient survival in 404 adult patients who underwent OLT at the University of California Los Angeles. The hazard rates of patient survival according to the MELD strata and United Network for Organ Sharing (UNOS) statuses were assessed by Proportional Hazard Cox regression analysis. The difference in survival for MELD strata and UNOS status were compared using the Cox model. There was a significant difference in 1-year patient (P =.0006) survival using different MELD strata, whereas there was a trend according to UNOS status (P =.051). Increased rate of death was observed in recipients of OLT with higher MELD scores (> 36, hazard ratio 3.9; 95% CI 1.55, 10.27) and more urgent UNOS status (2A, hazard ratio, 1.99; 95% CI 1.07, 3.7). The MELD stratum is better associated with 1-year patient survival in liver transplant recipients than UNOS statuses. Patient survival was worse with higher MELD scores.
引用
收藏
页码:473 / 476
页数:4
相关论文
共 15 条
[1]  
Armitage P., 2001, STAT METHODS MED RES, V4th
[2]   Model for End-Stage Liver Disease and Child-Turcotte-Pugh score as predictors of pretransplantation disease severity, posttransplantation outcome, and resource utilization in United Network for Organ Sharing status 2A patients [J].
Brown, RS ;
Kumar, KS ;
Russo, MW ;
Kinkhabwala, M ;
Rudow, DL ;
Harren, P ;
Lobritto, S ;
Emond, JC .
LIVER TRANSPLANTATION, 2002, 8 (03) :278-284
[3]  
CLEVES M, 2001, INTRO SURVIVAL ANAL
[4]  
Detre K M, 1995, Liver Transpl Surg, V1, P311, DOI 10.1002/lt.500010507
[5]   Preliminary results of a liver allocation plan using a continuous medical severity score that de-emphasizes waiting time [J].
Freeman, RB ;
Rohrer, RJ ;
Katz, E ;
Lewis, WD ;
Jenkins, R ;
Cosimi, AB ;
Delmonico, F ;
Friedman, A ;
Lorber, M ;
O'Connor, K ;
Bradley, J .
LIVER TRANSPLANTATION, 2001, 7 (03) :173-178
[6]  
Ghobrial R M, 2000, Clin Liver Dis, V4, P553, DOI 10.1016/S1089-3261(05)70126-4
[7]   A 10-year experience of liver transplantation for hepatitis C: Analysis of factors determining outcome in over 500 patients [J].
Ghobrial, RM ;
Steadman, R ;
Gornbein, J ;
Lassman, C ;
Holt, CD ;
Chen, P ;
Farmer, DG ;
Yersiz, H ;
Danino, N ;
Collisson, E ;
Baquarizo, A ;
Han, SS ;
Saab, S ;
Goldstein, LI ;
Donovan, JA ;
Esrason, K ;
Busuttil, RW .
ANNALS OF SURGERY, 2001, 234 (03) :384-393
[8]   Impact of anti-hepatitis Bc-positive grafts on the outcome of liver transplantation for HBV-related cirrhosis [J].
Joya-Vazquez, PP ;
Dodson, FS ;
Dvorchik, I ;
Gray, E ;
Chesky, A ;
Demetris, AJ ;
Shakil, O ;
Fung, JJ ;
Vargas, HE .
TRANSPLANTATION, 2002, 73 (10) :1598-1602
[9]   A model to predict survival in patients with end-stage liver disease [J].
Kamath, PS ;
Wiesner, RH ;
Malinchoc, M ;
Kremers, W ;
Therneau, TM ;
Kosberg, CL ;
D'Amico, G ;
Dickson, ER ;
Kim, WR .
HEPATOLOGY, 2001, 33 (02) :464-470
[10]  
Klein JP., 1997, SURVIVAL ANAL TECHNI, V149, P95